49. A SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF PD-(L)1 INHIBITORS FOR FIRST-LINE TREATMENT AMONG PATIENTS WITH HIGH PD-L1 EXPRESSION NON-SMALL CELL LUNG CANCER. YHCĐ [Internet]. 2024 Dec. 11 [cited 2026 Sept. 9];65(Tiếng Anh). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/1891